product safety governance philippe martin, mba, dea, ms, phd european commission directorate general...

Product Safety Governance

Philippe Martin, MBA, DEA, MS, PhDEuropean Commission

Directorate General for Health and Consumersphilippe.martin (at) ec.europa.eu

http://ec.europa.eu/health/index_en.htm#

Risk Governance of Manufactured Nanoparticles Brussels, 21 Nov 2011, 13.30 – 18.00

Outline• Nano risk governance• Products, claims, and regulation• The definition and what it means• What risk managers learn from risk

assessors

IRG

C (

200

7,

Fig.

1,

p.

23;

ww

w.irg

c.org

)

FP6 & FP7 safety research2004 “Mapping Nano Risks”SCENHIRSCCSEFSAEMA

IRG

C (

200

7,

Fig.

1,

p.

23;

ww

w.irg

c.org

)

200

6-2

01

0 A

ctio

n

Pla

n

IRG

C (

200

7,

Fig.

1,

p.

23;

ww

w.irg

c.org

)

IRG

C (

200

7,

Fig.

1,

p.

23;

ww

w.irg

c.org

)

Nano Safety for Success DialoguesPublic consultationsFP7 projects

2008 Review2nd (forthcoming) reviewInventoryJRC databaseDefinitionInt’l Regulators’ MeetingsTransatlantic Economic Council

IRG

C (

200

7,

Fig.

1,

p.

23;

ww

w.irg

c.org

)

Products, claims, and regulation

Substances (= REACH)

Consumer Products

Cosmetics

Food and feed

Medicines & Medical Devices

The definition and what it means

1 nm < < 100 nm 100 nm < < <

What risk managers learn from risk assessors

Exposure

Detection: Size, mass, contrast

Ag

NP

s in

mea

t: C

ourt

esy

Q.

Cha

udur

y

Hay

stac

k in

Buh

tan:

Flic

ker/

Cop

yrig

ht f

ree

Hazard

Risk assessment

Conclusion• Nano innovation potential

confirmed• Product safety framework in place• Guidelines to make it happen• No “sub-prime” risk assessment• S&T challenges to be addressed• Governance & engagement as key